Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT).
Hanna CR, O'Cathail SM, Graham JS, Saunders M, Samuel L, Harrison M, Devlin L, Edwards J, Gaya DR, Kelly CA, Lewsley LA, Maka N, Morrison P, Dinnett L, Dillon S, Gourlay J, Platt JJ, Thomson F, Adams RA, Roxburgh CSD.
Hanna CR, et al. Among authors: platt jj.
Radiat Oncol. 2021 Aug 26;16(1):163. doi: 10.1186/s13014-021-01888-1.
Radiat Oncol. 2021.
PMID: 34446053
Free PMC article.